HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoyuki Shirai Selected Research

Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)

1/2004Suppression of metastasis by nuclear factor kappaB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma.
10/2002Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoyuki Shirai Research Topics

Disease

57Neoplasms (Cancer)
09/2014 - 01/2002
51Carcinogenesis
02/2015 - 01/2002
48Prostatic Neoplasms (Prostate Cancer)
02/2015 - 01/2002
19Carcinoma (Carcinomatosis)
12/2013 - 01/2002
16Adenocarcinoma
02/2015 - 01/2002
11Hepatocellular Carcinoma (Hepatoma)
10/2013 - 05/2002
10Neoplasm Metastasis (Metastasis)
11/2013 - 10/2002
6Adenoma (Adenomas)
10/2013 - 02/2002
6Aberrant Crypt Foci
01/2011 - 02/2002
6Body Weight (Weight, Body)
01/2011 - 10/2002
5Prostatic Intraepithelial Neoplasia
08/2013 - 01/2006
4Fibrosis (Cirrhosis)
02/2009 - 04/2003
4Breast Neoplasms (Breast Cancer)
01/2009 - 12/2002
4Hyperplasia
03/2008 - 01/2002
3Papilloma (Papillomatosis)
01/2012 - 01/2002
3Hyperthermia
05/2008 - 09/2005
3Inflammation (Inflammations)
04/2005 - 04/2003
3Chronic Pancreatitis
04/2005 - 04/2003
2Osteolysis
01/2009 - 02/2008
2Bone Resorption
02/2008 - 01/2006
2Central Nervous System Neoplasms
10/2007 - 01/2005
2Atrophy
10/2006 - 04/2005

Drug/Important Bio-Agent (IBA)

17AndrogensIBA
02/2015 - 06/2002
13CarcinogensIBA
03/2008 - 10/2002
122- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
08/2013 - 01/2002
11Proteins (Proteins, Gene)FDA Link
05/2014 - 06/2002
10DNA (Deoxyribonucleic Acid)IBA
05/2014 - 05/2006
10benzocycloheptapyridineIBA
08/2013 - 02/2002
9probasinIBA
11/2009 - 03/2002
9Messenger RNA (mRNA)IBA
03/2008 - 02/2002
8Tumor Viral Antigens (Large T Antigen)IBA
11/2009 - 03/2002
7Diethylnitrosamine (N-Nitrosodiethylamine)IBA
08/2007 - 05/2002
6Androgen Receptors (Androgen Receptor)IBA
10/2012 - 03/2002
5Hormones (Hormone)IBA
09/2014 - 02/2003
5Testosterone (Sustanon)FDA Link
04/2014 - 03/2002
4AminesIBA
08/2013 - 01/2002
4N-nitrosomorpholineIBA
08/2007 - 10/2002
41,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
07/2003 - 02/2002
4Dimenhydrinate (DMH)FDA LinkGeneric
07/2003 - 02/2002
3DNA AdductsIBA
08/2013 - 05/2003
32- amino- 1- methyl- 6- phenolimidazo(4,5- b)pyridine- DNA adductIBA
08/2013 - 04/2002
3nobiletinIBA
01/2011 - 12/2004
3Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2009 - 04/2003
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2009 - 04/2005
3Transforming Growth Factor beta (TGF-beta)IBA
01/2009 - 02/2008
3Liposomes (Liposome)IBA
05/2008 - 09/2005
3Drinking WaterIBA
06/2007 - 10/2002
3IsoflavonesIBA
04/2006 - 12/2002
32',3-dimethyl-4-aminobiphenylIBA
01/2005 - 06/2002
3AntioxidantsIBA
12/2002 - 01/2002
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
03/2015 - 04/2003
2Caspase 3 (Caspase-3)IBA
02/2015 - 11/2009
2Ellagic AcidIBA
02/2015 - 01/2013
2acetovanillone (apocynin)IBA
12/2013 - 11/2013
2NADPH Oxidases (NAD(P)H oxidase)IBA
12/2013 - 11/2013
2Transcription Factors (Transcription Factor)IBA
10/2013 - 02/2005
2Glutathione PeroxidaseIBA
09/2013 - 12/2007
2Alkylating AgentsIBA
06/2013 - 05/2006
2CaspasesIBA
10/2012 - 05/2009
2candesartanIBA
10/2012 - 04/2005
2Connexin 43 (Connexin43)IBA
05/2012 - 11/2009
2Glutathione S-Transferase piIBA
04/2012 - 06/2008
2kuguacin JIBA
03/2012 - 07/2011
2Phosphotransferases (Kinase)IBA
10/2010 - 01/2009
2ConnexinsIBA
02/2010 - 08/2007
2ResveratrolIBA
11/2009 - 01/2008
2AntigensIBA
11/2009 - 02/2009
2Vitamin EFDA LinkGeneric
05/2009 - 01/2001
2LigandsIBA
01/2009 - 05/2002
2Small Interfering RNA (siRNA)IBA
06/2008 - 12/2007
2Androgen Antagonists (Antiandrogens)IBA
06/2008 - 01/2006
2ButylhydroxybutylnitrosamineIBA
03/2008 - 01/2002
2Bromodeoxyuridine (BrdU)IBA
03/2008 - 07/2003
2Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA
10/2007 - 01/2005
2Gap Junction beta-1 ProteinIBA
08/2007 - 01/2005
2auraptenIBA
04/2007 - 12/2004
2PhytochemicalsIBA
04/2007 - 12/2004
2Folic Acid (Vitamin M)FDA LinkGeneric
10/2006 - 01/2004
2Acetates (Acetic Acid Esters)FDA Link
06/2006 - 12/2004
2Ferrosoferric Oxide (Magnetite)FDA Link
05/2006 - 09/2005
2Lisinopril (Prinivil)FDA LinkGeneric
04/2005 - 04/2003
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2005 - 04/2003
2Sodium NitriteIBA
02/2005 - 12/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2005 - 01/2004
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2004 - 10/2002
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2004 - 10/2002
2Carotenoids (Carotene)IBA
09/2003 - 12/2002
2Safflower OilFDA Link
07/2003 - 04/2002
2Fatty Acids (Saturated Fatty Acids)IBA
07/2003 - 04/2002
2Conjugated Linoleic AcidsIBA
07/2003 - 04/2002
2phenethyl isothiocyanate (PEITC)IBA
07/2003 - 03/2003
2Caffeine (No Doz)FDA LinkGeneric
05/2003 - 01/2002
2Complementary DNA (cDNA)IBA
02/2003 - 02/2002
2TeaIBA
12/2002 - 01/2002
21-O-hexyl-2,3,5-trimethylhydroquinoneIBA
12/2002 - 02/2002

Therapy/Procedure

14Therapeutics
09/2014 - 02/2002
10Chemoprevention
03/2013 - 01/2002
5Castration
01/2015 - 02/2003
3Subcutaneous Injections
01/2004 - 12/2002
2Prostatectomy (Retropubic Prostatectomy)
01/2006 - 01/2002